Advances in Preoperative Risk Assessment and Management

Current Problems in Surgery

Volumn 49, Issue 1, 2012, Pages 11-40

  Bader, Angela M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUPRENORPHINE PLUS NALOXONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPTIFIBATIDE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; LONG ACTING INSULIN; METHADONE; METOPROLOL; METOPROLOL TARTRATE; NARCOTIC ANALGESIC AGENT; OPIATE; ORAL ANTIDIABETIC AGENT; PIG INSULIN; PLACEBO; SHORT ACTING INSULIN; TIROFIBAN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BARE METAL STENT; BLEEDING; CARDIOVASCULAR RISK; CHRONIC PAIN; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL PROTOCOL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INTRACARDIAC THROMBOSIS; LOW DRUG DOSE; MYOCARDIAL DISEASE; NEUROPATHIC PAIN; OCCLUSIVE CEREBROVASCULAR DISEASE; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PAIN; PATIENT CARE PLANNING; PATIENT REFERRAL; PERIOPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PREOPERATIVE EVALUATION; REPERFUSION INJURY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; STENT THROMBOSIS; STROKE; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNOLOGY; THROMBOPHILIA; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; UNSPECIFIED SIDE EFFECT; VENOUS THROMBOEMBOLISM;

CARDIAC SURGICAL PROCEDURES; DISEASE MANAGEMENT; HEART DISEASES; HUMANS; PREOPERATIVE PERIOD; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 84855979169     PISSN: 00113840     EISSN: 15356337     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2011.09.002     Document Type: Article

References (44)

1. Lema M.J. Using the ASA physical status classification may be a risky business. ASA Newsl 2002, 66:1-2.
2. Eagle K.A., Berger P.B., Calkins H., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002, 39:542-553.
3. Ashton C.M., Peterson N.J., Wray N.P., et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993, 188:504.
4. Katz R.I., Cimino L., Vitkun S.A. Preoperative medical consultations: impact on perioperative management and surgical outcome. Can J Anaesth 2005, 52:697.
5. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007, 116:e418-e499.
6. Lee T.H., Marcantonio E.R., Mangione C.M., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999, 100:1043-1049.
7. Eagle K.A., Berger P.B., Calkins H., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002, 39:542.
8. Boersma E., Poldermans D., Bax J.J., et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2011, 285(14):1865-1873.
9. McFalls E.O., Ward H.B., Moritz T.E., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004, 351:2795-2804.
10. Poldermans D., Boersma E., Bax J.J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999, 341:1789-1794.
11. Poldermans D. Beta-blockers: A panacea for coronary artery disease in patients undergoing general surgery?. SPAQI Newsletter 2007, 1:5-13. http://www.spaqi.org.
12. Cruickshank J.M. Beta-blockers continue to surprise us. Eur Heart J 2000, 21:354-364.
13. Flu W.J., van Kuijk J.P., Chonchol M., et al. Timing of pre-operative Beta-blocker treatment in vascular surgery patients: influence on post-operative outcome. J Am Coll Cardiol 2010, 56(23):1922-1929.
14. Devereaux P.J., Yang H., Yusef S., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008, 371(9627):1839-1847. POISE Study Group.
15. Poldermans D., Shouten O., Bax J., et al. Reducing cardiac risk in non-cardiac surgery: evidence from the DECREASE studies. Eur Heart J Suppl 2009, 11(suppl A):A9-A14.
16. Fleishmann K.E., Beckman J.A., Buller C.E., et al. ACCF/AHA focused update on perioperative beta blockade: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009, (120):2123-2151.
17. Dunkelgrun M., Boersma E., Schouten O., et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery. Ann Surg 2009, 249:921-926.
18. Angeli F., Verdecchia P., Karthikeyan G., et al. β-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery. Am J Cardiovasc Drugs 2010, 10(4):247-259.
19. Hindler K., Shaw A.D., Samuels J., et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006, 105:1260-1272.
20. Peters R.J., Mehta S.R., Fox K.A., et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the clopidogrel in unstable angina to prevent recurrent events (CURE) study. Circulation 2002, 108:1682-1687.
21. Horlocker T.T., Wedel D.J., Schroeder D.R., et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg 1995, 80:303-309.
22. Burger W., Chemnitius J.M., Kneissl G.D., et al. Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med 2005, 257:399-414.
23. Bélisle S., Hardy J.F. Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. Ann Thorac Surg 1996, 62:1908-1917.
24. Stage J., Jensen J.H., Bonding P. Post-tonsillectomy haemorrhage and analgesics. A comparative study of acetylsalicylic acid and paracetamol. Clin Otolaryngol Allied Sci 1988, 13:201-204.
25. Thurston A.V., Briant S.L. Aspirin and post-prostatectomy haemorrhage. Br J Urol 1993, 71:574-576.
26. Palmer J.D., Sparrow O.C., Iannotti F. Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 1994, 35:1061-1064.
27. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71-86. Antithrombotic Trialists' Collaboration.
28. Chassot P.G., Delabays A., Spahn D.R. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007, 99:316-328.
29. Chassot P.G., Delabays A., Spahn D.R. Perioperative use of antiplatelet drugs. Best Pract Res Clin Anaesthesiol 2007, 21:241-256.
30. Horlocker T.T., Wedel D.J., Rowlingson J.C., et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (third edition). Reg Anesth Pain Med 2010, 35(1):64-101.
31. Urmey W.F., Rowlingson J. Neuraxial anesthesia and analgesia in the presence of standard heparin. Reg Anesth Pain Med 1998, 23:157-163.
32. Bertrand M., Godet G., Meersschaert K., et al. Should the angiotensin II antagonists be discontinued before surgery?. Anesth Analg 2001, 92(1):26-30.
33. Auron M., Harte B., Kumar A., et al. Renin-angiotensin system antagonists in the perioperative setting: clinical consequences and recommendations for practice. Postgrad Med J 2011, 87(1029):472-481.
34. Benedetto U., Melina G., Capuano F., et al. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery. J Cardiovasc Med 2008, 9:1098-1103.
35. Licker M., Bednarkiewicz M., Neidhart P., et al. Preoperative inhibition of angiotensin-converting enzyme improves systemic and renal haemodynamic changes during aortic abdominal surgery. Br J Anaesth 1996, 76:632-639.
36. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 2011, 114:495-511. American Society of Anesthesiologists Committee.
37. Goldberger A.L., O'Konski M. Utility of the routine electrocardiogram before surgery and on general hospital admission. Critical review and new guidelines. Ann Intern Med 1986, 105:552-557.
38. Noordzij P.G., Boersma E., Bax J.J., et al. Prognostic value of routine preoperative electrocardiography in patients undergoing noncardiac surgery. Am J Cardiol 2006, 97:1103-1106.
39. Correll D.J., Hepner D.L., Chang C., et al. Preoperative electrocardiograms: patient factors predictive of abnormalities. Anesthesiology 2009, 110:1217-1222.
40. Tsen L.C., Segal S., Pothier M., et al. The effect of alterations in a preoperative assessment clinic on reducing the number and improving the yield of cardiology consultations. Anesth Analg 2002, 95:1563-1568.
41. Bader A.M., Sweitzer B.J., Kumar A. Nuts and bolts of preoperative clinics: the view from three institutions. Cleve Clin J Med 2009, 79:s104-s111.
42. Joint Commission. http://www.jointcommission.org.
43. http://www.asahq.org/For-Healthcare-Professionals/Standards-Guidelines-and-Statements.aspx.
44. http://www.acsnsqip.org/.